Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Jan;114(2):468–474. doi: 10.1111/j.1476-5381.1995.tb13250.x

Inhibitory action of SR33557 on L-type calcium current in single ventricular myocytes of rat.

K Yasui 1, P Palade 1
PMCID: PMC1510255  PMID: 7881746

Abstract

1. The effect of SR33557 on L-type Ca2+ currents in rat ventricular myocytes was investigated by use of the whole-cell patch-clamp technique. 2. SR33557 inhibited Ca2+ current (ICa) in a concentration-dependent manner without change in the current-voltage relationship. 3. The inhibitory effect of SR33557 on ICa was dependent on the holding potential (Vh). The IC50 values were estimated to be 2.2 x 10(-8) M at Vh = -50 mV and 9.0 x 10(-6) M at Vh = -80 mV. SR33557 (10(-7) M) shifted the steady state inactivation curve of ICa toward more negative potentials. Thus, the affinity of the drug for inactivated channels was considerably higher than for resting channels. 4. Blockade of ICa by SR33557 was both tonic and use-dependent. 5. The time constant of onset of block was 36.4 s at -50 mV and 41.9 +/- 11.1 s at -40 mV. 6. The time course of unblock was voltage-dependent. The time constant declined from 400.7 +/- 68.1 is at -50 mV to 5.2 +/- 1.2 s at -80 mV. 7. The rate of block of ICa was related to the number of openings per unit time and to the amount of time spent depolarized. The affinity of drug for open channels was considered to be similar to that for inactivated channels. 8. These results suggest that SR33557 inhibits L-type Ca2+ current through binding to both open and inactivated channels in rat ventricular myocytes.

Full text

PDF
468

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bean B. P., Cohen C. J., Tsien R. W. Lidocaine block of cardiac sodium channels. J Gen Physiol. 1983 May;81(5):613–642. doi: 10.1085/jgp.81.5.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bois P., Romey G., Lazdunski M. Indolizinsulphones. A class of blockers with dual but discriminative effects on L-type Ca2+ channel activity and excitation-contraction coupling in skeletal muscle. Pflugers Arch. 1991 Dec;419(6):651–656. doi: 10.1007/BF00370310. [DOI] [PubMed] [Google Scholar]
  3. Chatelain P., Beaufort P., Meysmans L., Clinet M. Characterization of the slow calcium channel binding sites for [3H]SR 33557 in rat heart sarcolemmal membranes. Mol Pharmacol. 1991 Jan;39(1):64–71. [PubMed] [Google Scholar]
  4. Chatelain P., Matteazzi J. R., Laruel R. Fluorescent studies on the interaction between a novel Ca2+ antagonist, SR 33557, and membrane lipids. Biochem Pharmacol. 1992 Apr 1;43(7):1513–1520. doi: 10.1016/0006-2952(92)90209-2. [DOI] [PubMed] [Google Scholar]
  5. Datyner N. B., Cohen I. S. Slow inactivation of L-type calcium current distorts the measurement of L- and T-type calcium current in Purkinje myocytes. J Gen Physiol. 1993 Nov;102(5):859–869. doi: 10.1085/jgp.102.5.859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Glossmann H., Ferry D. R., Goll A., Striessnig J., Zernig G. Calcium channels and calcium channel drugs: recent biochemical and biophysical findings. Arzneimittelforschung. 1985;35(12A):1917–1935. [PubMed] [Google Scholar]
  7. Hamill O. P., Marty A., Neher E., Sakmann B., Sigworth F. J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981 Aug;391(2):85–100. doi: 10.1007/BF00656997. [DOI] [PubMed] [Google Scholar]
  8. Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol. 1977 Apr;69(4):497–515. doi: 10.1085/jgp.69.4.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hille B. The pH-dependent rate of action of local anesthetics on the node of Ranvier. J Gen Physiol. 1977 Apr;69(4):475–496. doi: 10.1085/jgp.69.4.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hondeghem L. M., Katzung B. G. Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta. 1977 Nov 14;472(3-4):373–398. doi: 10.1016/0304-4157(77)90003-x. [DOI] [PubMed] [Google Scholar]
  11. Isenberg G., Klockner U. Calcium tolerant ventricular myocytes prepared by preincubation in a "KB medium". Pflugers Arch. 1982 Oct;395(1):6–18. doi: 10.1007/BF00584963. [DOI] [PubMed] [Google Scholar]
  12. Kenny B. A., Fraser S., Spedding M. Identification of a novel calcium antagonist binding site in rat brain by SR 33557. Br J Pharmacol. 1993 Jan;108(1):93–99. doi: 10.1111/j.1476-5381.1993.tb13445.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lee K. S., Tsien R. W. Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature. 1983 Apr 28;302(5911):790–794. doi: 10.1038/302790a0. [DOI] [PubMed] [Google Scholar]
  14. McDonald T. F., Pelzer D., Trautwein W. Cat ventricular muscle treated with D600: characteristics of calcium channel block and unblock. J Physiol. 1984 Jul;352:217–241. doi: 10.1113/jphysiol.1984.sp015288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nokin P., Clinet M., Beaufort P., Meysmans L., Laruel R., Chatelain P. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes. J Pharmacol Exp Ther. 1990 Nov;255(2):600–607. [PubMed] [Google Scholar]
  16. Nokin P., Clinet M., Polster P., Beaufort P., Meysmans L., Gougat J., Chatelain P. SR 33557, a novel calcium-antagonist: interaction with [3H]-(+/-)-nitrendipine and [3H]-(-)-desmethoxy-verapamil binding sites in cerebral membranes. Naunyn Schmiedebergs Arch Pharmacol. 1989 Jan-Feb;339(1-2):31–36. doi: 10.1007/BF00165122. [DOI] [PubMed] [Google Scholar]
  17. Sanguinetti M. C., Kass R. S. Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists. Circ Res. 1984 Sep;55(3):336–348. doi: 10.1161/01.res.55.3.336. [DOI] [PubMed] [Google Scholar]
  18. Schmid A., Romey G., Barhanin J., Lazdunski M. SR33557, an indolizinsulfone blocker of Ca2+ channels: identification of receptor sites and analysis of its mode of action. Mol Pharmacol. 1989 Jun;35(6):766–773. [PubMed] [Google Scholar]
  19. Sol-Rolland J., Joseph M., Rinaldi-Carmona M. Interaction of SR 33557 with skeletal muscle calcium channel blocker receptors in the baboon: characterization of its binding sites. J Pharmacol Exp Ther. 1991 May;257(2):595–602. [PubMed] [Google Scholar]
  20. Uehara A., Hume J. R. Interactions of organic calcium channel antagonists with calcium channels in single frog atrial cells. J Gen Physiol. 1985 May;85(5):621–647. doi: 10.1085/jgp.85.5.621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Yazawa K., Kaibara M., Ohara M., Kameyama M. An improved method for isolating cardiac myocytes useful for patch-clamp studies. Jpn J Physiol. 1990;40(1):157–163. doi: 10.2170/jjphysiol.40.157. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES